SetPoint Medical Delivers First FDA-Approved RA Device in N.C.
VALENCIA, Calif., June 29, 2026 SetPoint Medical has announced a significant milestone in the expansion of its FDA-approved SetPoint...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
VALENCIA, Calif., June 29, 2026 SetPoint Medical has announced a significant milestone in the expansion of its FDA-approved SetPoint...
BOCA RATON, Fla., June 2026 SurGenTec® has announced U.S. FDA clearance for its ION-L™ Lumbar Facet Fixation System, a...
VANCOUVER, British Columbia, May 14, 2026 Zymeworks Inc. announced that its Board of Directors has approved a new 2026...
VALENCIA, Calif., May 14, 2026 SetPoint Medical announced the publication of a peer-reviewed health economics study demonstrating that its...
TOKYO, Japan – March 1, 2026 Otsuka Medical Devices Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. announced that the...
